Left ventricular hypertrophy is associated with overexpression of HSP60, TLR2, and TLR4 in the myocardium
Autor: | Dražen Cuculić, Valter Stemberga, Antun Ferenčić, Bernard Šešo, Hrvoje Jakovac, Silvia Arbanas |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Male Clinical Biochemistry cardiomyocytes 030204 cardiovascular system & hematology Left ventricular hypertrophy BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Forensic Medicine 0302 clinical medicine TLR2 Myocytes Cardiac TLR4 BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Patofiziologija Aged 80 and over General Medicine Middle Aged BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Pathophysiology Myocardial hypertrophy cardiovascular system Cardiology HSP60 Female Hypertrophy Left Ventricular Autopsy Signal Transduction Adult medicine.medical_specialty animal structures Mitochondrial Proteins 03 medical and health sciences Internal medicine medicine Humans overexpression Aged business.industry Myocardium fungi BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Sudska medicina Chaperonin 60 medicine.disease Toll-Like Receptor 2 Toll-Like Receptor 4 030104 developmental biology Death Sudden Cardiac Gene Expression Regulation Case-Control Studies business |
Zdroj: | Scandinavian Journal of Clinical and Laboratory Investigation |
ISSN: | 0036-5513 1502-7686 |
DOI: | 10.1080/00365513.2020.1725977 |
Popis: | Left ventricular hypertrophy is a common adaptive response to increased cardiac workload. Cardiomyocytes growth and increase in contractile force are conditioned by sufficient energy production, which implies appropriate mitochondrial function. The 60kDa heat shock protein (HSP60) is a chaperone essential for mitochondrial proteostasis, but when translocates from mitochondria, it can also act as a potent inflammatory mediator binding to toll-like receptors (TLRs). In this study, we aimed to compare the expression pattern of HSP60, TLR2, and TLR4 in hypertrophic vs non-hypertrophic, normal human myocardium. We further examined whether HSP60 in situ binds to TLRs in hypertrophic myocardial tissue. In addition, expression of activated downstream targets of TLR 2/4 pathways was also evaluated. For this purpose, immunohistochemical expression analyses were performed on myocardial tissue samples obtained during the autopsy of human subjects in which left ventricular hypertrophy was the only cardiopathological finding and had died from sudden cardiac death, as well as from the subjects without any cardiac pathology, that died by unnatural death (accident or suicide). Double immunofluorescence was used to examine HSP60 translocation, while proximity ligation assay (PLA) was performed to assess HSP60 and TLRs interactions. Hypertrophic myocardium showed significantly higher expression of HSP60, TLR2, and TLR4 compared to normal myocardium. Furthermore, in hypertrophic cardiomyocytes, we found membrane translocation of HSP60 and signs of HSP60/TLR interactions. Conclusion: The obtained data point to an important supportive role of HSP60 in adaptive cardiomyocytes growth, while concomitant induction of TLR2 and TLR4 candidates HSP60-TLRs interactions as an early events duriing pathogenesis of secondary complications consequently to the left ventricular hypertrophy. |
Databáze: | OpenAIRE |
Externí odkaz: |